Key Metrics of Beyond Air Inc.
Revenue$1.2MFY 2023
Operating income−$63.0M▼ 21.0% YoY
Net profit−$64.3M▼ 15.2% YoY
Shareholders' equity$20.8M
Market cap$3.7MXAIR · $2.21
Competitors10identified
About Beyond Air Inc.
Sectors
Company details
- Listed
- Nasdaq: XAIR
Operational Areas of Beyond Air Inc.
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameBeyond Air Inc.
TickerXAIR
ExchangeNasdaq
CountryUnited States
SEC CIK0001641631
Listed since—
IndustryMedical/Dental Instruments
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Website—
US market & SEC filings
XAIR · Nasdaq · SEC CIK 0001641631
Last price · 29 Oct 2026
$2.21
+3.27%
Market cap$3.7M
P/E—On FY 2023 diluted EPS
Volume10,461
SectorHealth CareMedical/Dental Instruments
Country · IPOUnited States
XAIR share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office—
GSTIN—
Email—
Website—
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Beyond Air Inc.
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States |
Similar companies
S
SMS Pharmaceuticals LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
E
Entero Healthcare Solutions LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
T
Tatva Chintan Pharma Chem LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
V
Valiant Laboratories LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
C
Cohance Lifesciences LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
M
Metropolis Healthcare LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
P
Par Drugs And Chemicals LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
B
Balaxi Pharmaceuticals LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.